December 4, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
| Attn: | Franklin Wyman, Angela Connell, Irene Paik and Mary Beth Breslin |
| Re: | DiaMedica Therapeutics Inc. |
|
Registration Statement on Form S-1, as amended |
|
| File No. 333-228313 | |
| Request for Acceleration |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, DiaMedica Therapeutics Inc. hereby respectfully requests that the effective date of the above-referenced registration statement be accelerated so that it will be declared effective at 3:30 p.m., Eastern Time, on December 6, 2018, or as soon thereafter as is practicable.
Thank you for your assistance in this matter. Should you have any questions, please call Amy Culbert of Fox Rothschild LLP at (612) 607-7287.
Very truly yours,
/s/ Rick Pauls
Rick Pauls
President and Chief Executive Officer